In vitro antimyeloma activity of the iron chelator deferasirox (DFX).

被引:0
|
作者
Willenbacher, Ella [1 ]
Willenbacher, Wolfgang [1 ]
Funk, Ulrike [1 ]
Kircher, Brigitte [1 ]
机构
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19587
引用
收藏
页数:1
相关论文
共 50 条
  • [1] DEFERASIROX (DFX), A NEWLY ORAL IRON CHELATOR, WITH GEMCITABINE (GEM) INHIBITED PANCREATIC CANCER CELL PROLIFERATION AND INDUCED APOPTOSIS IN VITRO AND IN VIVO
    Shinoda, Shuhei
    Kaino, Seiji
    Amano, Shogo
    Matsumoto, Toshihiko
    Fujisawa, Koichi
    Takami, Taro
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Sakaida, Isao
    GASTROENTEROLOGY, 2017, 152 (05) : S273 - S274
  • [2] Deferasirox (Exjade):: A new iron chelator
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1233): : 35 - 36
  • [3] Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
    Hirofumi Harima
    Seiji Kaino
    Taro Takami
    Shuhei Shinoda
    Toshihiko Matsumoto
    Koichi Fujisawa
    Naoki Yamamoto
    Takahiro Yamasaki
    Isao Sakaida
    BMC Cancer, 16
  • [4] Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
    Harima, Hirofumi
    Kaino, Seiji
    Takami, Taro
    Shinoda, Shuhei
    Matsumoto, Toshihiko
    Fujisawa, Koichi
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Sakaida, Isao
    BMC CANCER, 2016, 16
  • [5] Deferasirox: The new oral iron chelator
    Dubey, A. P.
    Sudha, S.
    Parakh, Ankit
    INDIAN PEDIATRICS, 2007, 44 (08) : 603 - 607
  • [6] IN VITRO AND IN VIVO EFFECT OF AN ORAL IRON CHELATOR DEFERASIROX IN MYELOID LEUKEMIA CELLS
    Choi, C. W.
    Kim, J. L.
    Kang, H. N.
    Kang, M. H.
    Yoo, Y. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 268 - 268
  • [7] Deferasirox.: Treatment of iron overload, iron chelator
    McIntyre, JA
    Castañer, J
    Mealy, NE
    Bayés, M
    DRUGS OF THE FUTURE, 2004, 29 (04) : 331 - 335
  • [8] Deferasirox, a Newly Developed Oral Iron Chelator, Showing Antiproliferative Activity Against Pancreatic Cancer In Vitro and In Vivo
    Harima, Hirofumi
    Kaino, Seiji
    Shinoda, Shuhei
    Matsumoto, Toshihiko
    Fujisawa, Koichi
    Takami, Taro
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Sakaida, Isao
    GASTROENTEROLOGY, 2016, 150 (04) : S329 - S330
  • [9] Deferasirox, an oral chelator in the treatment of iron overload
    Portioli, I.
    ITALIAN JOURNAL OF MEDICINE, 2007, 1 (04) : 35 - 40
  • [10] Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator
    Salehi, Samie
    Saljooghi, Amir Sh.
    Shiri, Ali
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 781 : 209 - 217